Should antiviral treatment be extended to patients with chronic hepatitis B and mildly elevated alanine aminotransferase?†‡
See Article on Page 1185.
Potential conflict of interest: Dr. Lok is a consultant for and received grants from Bristol-Myers Squibb, Gilead, and Roche. She also received grants from Glaxo-SmithKline, Novartis, and Schering-Plough.
No abstract is available for this article.